Pre-and post-operative chemotherapy for hepatic metastases from resectable colorectal cancer

VernacularTitle:可切除结直肠癌肝转移患者的术前和术后化疗
Author: Rongbo LIN ; Nanfeng FAN ; Ling CHEN
Publication Type:Journal Article
Keywords: Colorectal neoplasms; Liver; Neoplasms metastasis; Adjuvant,chemotherapy
From: Journal of International Oncology 2009;36(4):306-308
CountryChina
Language:Chinese
Abstract: Relapse may occur in about 75% of patients who experienced the resection of hepatic metas-tases from coloreetal cancer. Perioperative chemotherapy with 5-fluorouraeil, leucovorin and oxaliplatin (FOLFOX) can reduce the risk of disease progression in eligible and reseeted patients compared with surgery a-lone. Pre-operative chemotherapy may cause vascular changes and steatohepatitis, which has the potential to in-crease the risks of surgery. A pooled analysis shows a trend of a longer median progression-free survival dura-tion among pest-operative patients who received adjuvant chemotherapy with 5-fluorouraeil and leueovorin-based regimen. Bevaeizumab in either pre-or pest-operative chemotherapy does not increase surgical complications.How to choose the best time and duration of the ebemotherapy needs to be further studied.